A meta-analysis of these studies indicated a statistically significant increased risk of breast cancer recurrence in insulin users vs. non-users (HR = 1.43, 95% CI: 1.13–1.80; p = 0.003) [32]. The gene discussed is INS; the disease is breast carcinoma.